RGS14 is a multifunctional scaffolding protein possessing two distinct G protein interaction sites including a regulator of G protein signaling (RGS) domain that acts as a GTPase activating protein (GAP) to deactivate Gai/o-GTP proteins, and a G protein regulatory (GPR) motif that binds inactive Gai1/3-GDP proteins independent of Gbc. GPR interactions with Gai recruit RGS14 to the plasma membrane to interact with Gai-linked GPCRs and regulate Gai signaling. While RGS14 actions on Ga proteins are well characterized, consequent effects on Gbc signaling remain unknown. Conventional RGS proteins act as dedicated GAPs to deactivate Ga and Gbc signaling following receptor activation. RGS14 may do the same or, alternatively, may coordinate its actions to deactivate Ga-GTP with the RGS domain and then capture the same Ga-GDP via its GPR motif to prevent heterotrimer reassociation and prolong Gbc signaling. To test this idea, we compared the regulation of G protein activation and deactivation kinetics by a conventional RGS protein, RGS4, and RGS14 in response to GPCR agonist/antagonist treatment utilizing bioluminescence resonance energy transfer (BRET). Co-expression of either RGS4 or RGS14 inhibited the release of free Gbc after agonist stimulation and increased the deactivation rate of Ga, consistent with their roles as GTPase activating proteins (GAPs). Overexpression of inactive Gai1 to recruit RGS14 to the plasma membrane did not alter RGS14 0 s capacity to act as a GAP for a second Gao protein. These results demonstrate the role of RGS14 as a dedicated GAP and suggest that the G protein regulatory (GPR) motif functions independently of the RGS domain and is silent in regulating GAP activity in a cellular context.
Introduction
Canonical G protein-coupled receptor (GPCR) signaling begins with binding of an extracellular ligand to the receptor. Upon conformational rearrangement of the GPCR, the receptor is able to stimulate the exchange of GDP for GTP in the Ga subunit of the heterotrimeric G protein (Gabc) (Bourne 1997) . Binding of GTP by Ga results in rearrangement and sometimes dissociation of the Gabc heterotrimer, allowing both Ga and Gbc to signal to downstream effector molecules (Gilman 1987; Hepler and Gilman 1992; Hamm 1998) . Regulators of G protein signaling (RGS) proteins negatively regulate G protein signaling by serving as GTPase activating proteins (GAPs) that stimulate the intrinsic GTPase of the Ga subunit. Upon hydrolysis of GTP to GDP, Ga rebinds Gbc thereby terminating the G protein signaling event (De Vries et al. 2000; Ross and Wilkie 2000; Hollinger and Hepler 2002) .
Many RGS proteins have a relatively simple structure, lacking domains outside the canonical RGS domain. However, other RGS proteins have a more complicated structure. One such protein, RGS14, is a multifunctional scaffold that is highly expressed in the brain (Traver et al. 2000 ; Lee et al. 2010; Evans et al. 2014) , and has been identified as a natural suppressor of synaptic plasticity in CA2 hippocampal neurons and of hippocampal-based learning and memory (Lee et al. 2010) . As a member of the R12 family of RGS proteins, RGS14 possesses an N-terminal RGS domain that engages Gai/o family members (Cho et al. 2000; Traver et al. 2000; Hollinger et al. 2001 ). In addition, RGS14 also has a C-terminal G protein regulatory (GPR) motif (Hollinger et al. 2001; Kimple et al. 2001 ) and two tandem Ras/Rap-binding domains (RBDs) (Traver et al. 2000) . The GPR motif binds inactive Gai1/3 proteins while the first RBD binds activated Ras/Rap proteins (Traver et al. 2000; Mittal and Linder 2004; Willard et al. 2009; Shu et al. 2010; Vellano et al. 2013) .
Given its unique molecular architecture, RGS14 is primed to intercept incoming Ga signals. Previously we showed that activation of Gai/o proteins can recruit cytosolic RGS14 to the plasma membrane through the RGS domain (Brown et al. 2015b ). Moreover, co-expression of inactive Gai1 targets RGS14 to the plasma membrane through the GPR motif (Shu et al. 2007; Brown et al. 2015b ) where RGS14 can form a Ga-dependent complex with GPCRs (Vellano et al. 2013) . Considering these two distinct Ga-interacting sites, we have proposed a model of RGS14 function (Brown et al. 2015b ) in which the RGS domain "senses" G protein activation, thereby recruiting cytosolic RGS14 to the plasma membrane. At the membrane, RGS14 accelerates the GTPase of the Ga to hydrolyze GTP to GDP. At this time, RGS14 would then be optimally positioned to bind the newly formed Ga-GDP through its GPR motif and form a stable complex at the plasma membrane. Alternatively, a subset of RGS14 may exist in a preformed complex with Gai-GDP at the plasma membrane, independent of Gbc.
Previous studies have indicated that the binding of Ga by Gbc and the GPR motif of RGS14 are mutually exclusive (Mittal and Linder 2006; Shu et al. 2007 ). In support of this idea, structural characterization demonstrated that the binding site of the RGS14 GPR motif on Ga overlaps with that of Gbc (Kimple et al. 2002) . While biochemical studies have suggested the RGS14 GPR motif cannot disrupt preformed Gabc heterotrimers (Mittal and Linder 2006) , other studies have suggested the GPR motif may prevent heterotrimer reassembly after GPCR stimulation (Webb et al. 2005 ). As such, RGS14 interference with the reassociation of Ga with Gbc may prolong Gbc signaling. To test the idea that RGS14 might prolong Gbc signaling more than conventional RGS proteins, we utilized a bioluminescence resonance energy transfer (BRET) based biosensor for Gbc release to monitor the activation and deactivation of heterotrimeric G proteins that interact with RGS14 (Gao and Gai1) . Using this biosensor, we compared RGS4, a conventional RGS protein, with the unconventional RGS14 to understand the regulation of G protein heterotrimers. We examined whether RGS14 interrupts formation of Gabc heterotrimers by examining basal BRET ratios prior to agonist addition. Additionally, we examined whether BRET signals returned to baseline after antagonist addition to assess whether RGS14 disrupts heterotrimer reassembly after a signaling event.
Here, we show that co-expression of RGS4 or RGS14 each limits the release of free Gbc as well as stimulates the deactivation rate of G proteins in live cells. RGS14 does not appear to interfere with formation of Gabc heterotrimers either before or after receptor stimulation. Co-expression of inactive Gai1 with RGS14 did not alter the GAP effect on Gao proteins. Based on these findings, we propose that the RGS domain and the GPR motif of RGS14 function independently in live cells.
Materials and Methods
Cell culture and transfection HEK 293 cells were maintained in 19 Dulbecco's modified Eagle's medium without phenol red indicator supplemented with 10% fetal bovine serum (5% after transfection), 2 mmol/L L-glutamine, 100 units/mL penicillin, and 100 mg/mL streptomycin. Cells were kept in a 37°C incubator supplied with 5% CO 2 . Transfections were carried out using polyethyleneimine (PEI) as described previously (Brown et al. 2015a ).
Constructs and reagents
The hemagglutinin (HA) epitope-tagged a2a-adrenergic receptor (HA-a2a-AR) used in this study was kindly provided by Dr. Joe Blumer (Medical University of South Carolina).
Hemagglutinin epitope-tagged RGS4 (HA-RGS4) and FLAG-tagged RGS14 (FLAG-RGS14) were generated as described previously (Bernstein et al. 2004; Shu et al. 2007 ). The pertussis-resistant mutants (C351G) of Gao and Gai1 were purchased from the cDNA Resource Center (cDNA.org, Bloomsberg, PA). Mas-GRK3ct-Luc and Ven-Gbc were described previously (Hollins et al. 2009 ). UK 14,304 was obtained from Sigma-Aldrich (St. Louis, MO) while rauwolscine was purchased from Tocris Bioscience (Bristol, United Kingdom). Pertussis toxin was purchased from List Biological Laboratories, Inc (Campbell, CA).
Kinetic BRET assay
For kinetic BRET experiments, HEK 293 cells seeded in six-well plates were transfected with 25 ng mas-GRK3ct-Luc, 200 ng HA-a2A-AR, 200 ng Ven-Gb1, 200 ng VenGc2, and 400 ng of either Gao-C351G or Gai1-C351G. HA-RGS4 or FLAG-RGS14 was also transfected in 3, 10, 30, and 100 ng amounts. For each experiment, a control using pertussis-sensitive Gao or Gai1 was included to record any noise within the system. Pertussis toxin (100 ng/mL) was added at the time of transfection to limit activation of endogenous G proteins. Cells were transfected for 24 h before resuspension in Tyrode's solution (140 mmol/L NaCl, 5 mmol/L KCl, 1 mmol/L MgCl 2 , 1 mmol/L CaCl 2 , 0.37 mmol/L NaH 2 PO 4 , 24 mmol/L NaHCO 3 , 10 mmol/L HEPES, and 0.1% glucose, pH 7.4) and plated on white 96-well Optiplates (Perkin Elmer Life Sciences, Waltham, MA). Fluorescence measurements to confirm acceptor expression were made using the TriStar LB 941 plate reader (Berthold Technologies, Bad Wildbad, Germany) with 485-nm excitation and 530-nm emission filters. After a 5 min application of 5 lmol/L coelenterazine H (Nanolight Technologies, Pinetop, AZ), kinetic BRET was monitored using sequential measurements through 485-and 530-nm emission filters. BRET was recorded for 30 sec with no stimulation to establish basal BRET. After basal BRET measurements, agonist was applied for 60 sec followed by 90 sec of antagonist application. The change in BRET (DBRET) was calculated by dividing the masGRK3ct-Luc signal (530 nm) by the Ven-Gbc signal (485 nm) and subtracting the average BRET signal observed from the first 30 sec of observation (basal BRET). With each experiment, a kinetic BRET control was performed utilizing pertussis-sensitive Ga to ensure the effectiveness of the pertussis toxin. Any signal recorded in these controls was regarded as noise and subtracted from experimental kinetic BRET recordings. Data were collected using the MikroWin 2000 software (Mikrotek Laborsysteme GmbH, Overath, Germany) and analyzed using Microsoft Excel and GraphPad Prism 5. Deactivation curves were fitted to a single-phase decay exponential function. Statistical data analysis was performed using a one-way analysis of variance (ANOVA) with Tukey's or Dunnett's post hoc test where indicated.
Immunoblotting
Representative immunoblots were performed using primary antibodies for a2A-AR, Gao, and Gai1 from Santa Cruz Biotechnology. Primary GFP antibodies (MBL International) were used to detect Venus-Gb expression while mas-GRK3ct-Luc expression was assessed with the antiLuciferase antibody from Millipore. HRP-conjugated FLAG antibodies (Sigma) were used to detect FLAGtagged RGS14 constructs. Proteins were then detected with enhanced chemiluminescence.
Results
Activation of a2a-AR releases free Gbc from Gao and Gai1 proteins
The goal of these studies was to compare the regulation of G protein activation and deactivation and Gbc signaling in live cells by a conventional RGS protein (RGS4) and an unconventional RGS protein containing a second G protein-binding GPR motif (RGS14) . Ideally, this would involve measuring the real-time kinetics of Ga and Gbc dissociation and reassociation directly in live cells. Our initial studies attempted this using a live cell BRET assay with luciferase-tagged Gai (Gai-Luc) and a Venustagged Gbc (Gbc-Ven), activated with an appropriate Gai/o-coupled GPCR. However, we were unable to detect significant heterotrimer dissociation following receptor activation using this assay (data not shown), consistent with previous reports of G protein heterotrimer rearrangement in cells (Bunemann et al. 2003; Hepler 2014) .
As an alternative approach, we took advantage of a previously reported live cell biosensor assay for Gbc activation that involves transfecting into cells a GPCR, Ga protein, Gbc, and a biosensor for Gbc activation (Fig. 1A) . The biosensor for Gbc activation, designated as mas-GRK3ct-Luc (Hollins et al. 2009 ), features the Cterminal Gbc-binding region of G protein-coupled receptor kinase 3 (GRK3). A myristate attachment sequence (mas) was attached to the N-terminus of the GRK3 Gbcbinding domain while Renilla Luciferase (RLuc8) was attached to the C-terminus. The mas sequence allows the Gbc biosensor to be targeted to the plasma membrane while the Luciferase tag serves as a BRET donor. A bimolecular fluorescence complementation technique was employed to generate a Venus-Gb1c2 BRET acceptor. Residues 156-239 of Venus were fused to the N-terminus of Gb1 while residues 1-155 of Venus were fused to the N-terminus of Gc2. Upon heterodimerization, the Venus-tagged Gb1c2 constructs form a functional Gbc subunit (Hollins et al. 2009; Hynes et al. 2011) . We chose this Gbc biosensing system because the mas-GRK3ct-Luc biosensor provides a clear indication of heterotrimer activation (Hollins et al. 2009; Masuho et al. 2015a,b) . Additionally, we chose the a2A-adrenergic receptor as we have studied it previously and demonstrated that RGS14 can associate with the receptor in a Gai1-dependent manner (Vellano et al. 2011 (Vellano et al. , 2013 .
HEK 293 cells were transfected with the a2A-adrenergic receptor (a2A-AR), mas-GRK3ct-Luc, Venus-Gbc and either Gao or Gai1, each containing a mutation conferring pertussis toxin-resistance (C351G) and then treated with pertussis toxin to eliminate signaling contributions from endogenous G proteins. Addition of a2a-AR agonist UK 14,304 (1 lmol/L) activates the G protein heterotrimer and produces dissociation of the Ga and Gbc subunits. Free Gbc binds the Gbc activation biosensor as indicated by the rise in DBRET (Fig. 1B) . After 60 sec of agonist application, addition of a2a-AR antagonist rauwolscine (100 lmol/L) rapidly halts activation of G proteins and allows Ga proteins to hydrolyze GTP to GDP. Gbc dissociates from the Gbc biosensor to reform a heterotrimer with Ga as indicated by a decrease in DBRET.
Agonist-induced activation of Gao proteins generated a larger DBRET than Gai1. Cells expressing Gao produced a maximum DBRET of 0.129 (AE0.020 SE) while cells expressing Gai1 produced a maximum DBRET of 0.040 (AE0.002 SE) (Fig. 1B) . These results are consistent with other reports suggesting Gai1 proteins do not release as much free Gbc as Gao proteins (Digby et al. 2008; Masuho et al. 2015b ).
Expression of RGS4 reduces the release of free Gbc and accelerates the deactivation rate of G proteins
To determine the effect of an RGS protein on free Gbc release, we co-expressed increasing amounts of RGS4 (Figs. 2A, 3A). We chose RGS4 because it is a well-studied RGS protein that features a relatively simple protein structure, lacking domains outside the RGS domain. In cells expressing Gao, expression of 100 ng of RGS4 significantly reduced the maximum DBRET from 0.112 (AE0.010 SE) to 0.078 (AE0.003 SE, P < 0.01) (Fig. 2B ). In cells expressing Gai1, co-expression of RGS4 did not result in a significant decrease in maximum DBRET though a trend appears to be present (Fig. 3B) .
We then examined the effect of an RGS on G protein deactivation. The association of Gbc with the biosensor is governed by the activation state of Ga. Upon heterotrimer activation and formation of Ga-GTP, Gbc is released and binds the Gbc biosensor. Upon hydrolysis of GTP to GDP, Ga-GDP regains affinity for Gbc and Gbc dissociates from the biosensor to reassociate with Ga-GDP. As Gbc association with the biosensor is directly tied to the activation state of Ga, the deactivation rate serves as an indirect measure of the Ga GTPase rate (Lambert et al. 2010) . To determine the deactivation rate, we fit the BRET curve dissociation phase with a single-phase exponential decay function (Figs. 2C, 3C ).
In cells expressing Gao alone, the deactivation rate was determined to be 0.057 sec À1 (AE0.004 SE) (Fig. 2D) . In cells expressing 100 ng RGS4, the deactivation rate increased significantly to 0.095 sec
À1
(AE0.006 SE, P < 0.01). In cells expressing Gai1, 100 ng of RGS4 expression significantly increased the deactivation rate from 0.044 sec À1 (AE0.001 SE) to 0.083 sec À1 (AE0.005 SE, P < 0.01) (Fig. 3D) . These results correspond with the decreased maximum DBRET observed in Figures 2B, 3B and highlight the utility of the Gbc biosensor in detecting free Gbc release.
Expression of RGS14 reduces the release of free Gbc and accelerates the deactivation rate of G proteins
We then sought to compare the effects of RGS14 with RGS4 on the release of Gbc and deactivation rate. Unlike most RGS proteins including RGS4, RGS14 contains tandem RBDs and a GPR motif in addition to the RGS domain that could regulate the RGS14 effects on G protein heterotrimer activity. Similar to RGS4 (Figs. 2, 3 ), increasing expression of RGS14 reduced the maximum DBRET observed in both Gao-and Gai1-expressing cells (Figs. 4A, 5A ). In cells expressing Gao, co-expression of 100 ng of RGS14 decreased the maximum DBRET from 0.129 (AE0.020 SE) to 0.023 (AE0.009 SE, P < 0.01) (Fig. 4B) . Similar results were obtained in cells expressing Gai1 where the maximum DBRET recorded for Gai1 decreased from 0.040 (AE0.002 SE) to 0.014 (AE0.001 SE P < 0.05) in cells co-expressing 100 ng RGS14 (Fig. 5B) . These results indicate that RGS14 limits the release of free Gbc from both Gao and Gai1 proteins.
Next, we determined the deactivation kinetics of G proteins in response to RGS14 expression (Figs. 4C, 5C ). In conditions transfected with 100 ng of RGS14, the DBRET was not large enough to reliably fit the deactivation curve, thus we limited this analysis to conditions transfected with 0, 3, 10, and 30 ng of RGS14. In cells expressing Gao, the deactivation rate was 0.067 sec À1 (AE0.006 SE) (Fig. 4D ).
Co-expression of 30 ng of RGS14 significantly increased the deactivation rate to 0.120 sec À1 (AE0.006 SE, P < 0.05), indicative of RGS14 GAP activity. In cells expressing Gai1, the deactivation rate was 0.049 sec À1 (AE0.003 SE) which increased to 0.080 sec À1 (AE0.004 SE)
upon co-expression of 30 ng of RGS14 (Fig. 5D ).
RGS14 does not interrupt formation of Gabc heterotrimers
To assess whether RGS14 alters the formation of Gabc heterotrimers prior to agonist stimulation, we then examined the basal BRET. As the GPR motif only interacts with Gai1/3 proteins, we did not expect RGS14 to alter basal BRET of Gao proteins. Prior to activation with receptor agonist, we recorded a basal DBRET value of 0.00 (AE0.003 SE). Upon expression of RGS14, no significant difference in basal DBRET values was observed across a range of increasing RGS14 amounts (Fig. 4E ). For Gai1, we observed a basal DBRET value of 0.00 (AE0.004 SE) and no significant difference was observed upon expression of increasing amounts of RGS14 (Fig. 5E ). These results suggest co-expression of RGS14 does not alter the basal formation of Gabc heterotrimers. Additionally, based on previous observations (Webb et al. 2005; Mittal and Linder 2006) , we predicted that RGS14 may be able to interfere with the capacity of the Gai1 and Gbc subunits to reform a heterotrimer. If RGS14 binding to Gai1 through the GPR motif prevented Gbc from rebinding Gai1, we would not expect the DBRET to return to baseline after addition of antagonist. Upon examination of deactivation curves, we did not observe any significant difference in the return to baseline after addition of antagonist. These results suggest that RGS14 does not interfere with heterotrimer reformation after receptor stimulation.
RGS-null mutant of RGS14 cannot accelerate
GTPase while the GPR-null RGS14 mutant retains GAP activity Next, to elucidate the roles of the RGS domain and GPR motif on heterotrimer kinetics, we employed RGS-null and GPR-null mutants of RGS14 (Fig. 6) . To examine whether the accelerated deactivation rates were due to the RGS domain, we employed an RGS-null mutation of RGS14 (E92A/N93A). In cells expressing Gao, co-expression of 30 ng RGS-null RGS14 resulted in a deactivation rate of 0.065 sec À1 (AE0.009 SE), which did not differ from Gao alone. Moreover, expression of a GPR-null mutant of RGS14 (Q515A/R516A) increased the deactivation rate to 0.132 sec À1 (AE0.012 SE), which did not differ from RGS14-WT. Similar results were obtained in cells co-expressing RGS14 mutants with Gai1 proteins (Fig. 7) . Expression of 30 ng of RGS-null RGS14 resulted in a deactivation rate of 0.052 sec À1 (AE0.004 SE), which did not differ from Gai1 alone. Expression of 30 ng of GPR-null RGS14 resulted in a deactivation rate of 0.093 sec À1 (AE0.009 SE), which did not differ from RGS14-WT. 
RGS14 GAP function on Gao is unaltered by GPR binding of Gai1
Our previous investigations of RGS14 revealed that, when bound to an inactive Ga at the GPR motif, RGS14 undergoes conformational rearrangements within the RGS domain (Brown et al. 2015b) . Upon measurement of RGS domain function utilizing in vitro GTPase assays, the preformed RGS14:Gai1-GDP complex showed no difference in its ability to catalyze GTPase activity in Gao when compared to apo-RGS14 (Brown et al. 2015b ). Thus, despite binding an inactive G protein to the GPR motif, RGS14 retained RGS function to stimulate the GTPase of a second Ga at the RGS domain (Brown et al. 2015b ). Moreover, we were able to demonstrate the capacity of RGS14 to form a ternary complex with an inactive Ga at the GPR motif and an active Ga at the RGS domain (Brown et al. 2015b ).
To further demonstrate the role of the GPR motif in regulating RGS function in live cells, we examined whether co-expression of Gai1 altered RGS14 effects on Gao heterotrimers (Fig. 8A) . For these experiments, we utilized pertussis-resistant Gao and pertussis-sensitive Gai1 proteins to ensure that the recorded signal was due to Gao activation. As a control, we examined the interaction with RGS14 and Gai1 in the presence and absence of pertussis toxin. While treatment with pertussis toxin uncouples G proteins from GPCRs, pertussis toxin treatment did not alter the interaction between Gai1 and the GPR motif of RGS14 (Fig. 8B) .
In cells expressing Gao, co-expression of 10 ng of RGS14 ( Fig. 8C ) resulted in a maximum DBRET of 0.0862 (AE0.006 SE) ( Fig. 8D and E) . Upon co-expression of RGS14 and 300 ng of pertussis-sensitive Gai1, the observed maximum DBRET was 0.0830 (AE0.007 SE) ( Fig. 8D and E) , demonstrating no difference from RGS14 expressed alone. Co-expression of a GPR-null (RGS14-515/516) confirmed the observed effect on DBRET was due to an intact RGS domain (Fig. 8E) . Additionally, the enhanced deactivation rate observed with expression of RGS14 was unchanged with co-expression of Gai1. In cells expressing RGS14 alone, the observed deactivation rate was 0.110 sec À1 (AE0.009 SE) while cells expressing RGS14 and 300 ng of pertussis-sensitive Gai1 demonstrated an observed deactivation rate of 0.1023 sec À1 (AE0.009 SE) ( Fig. 8F and G) . Co-expression of either RGS14 or RGS14 and Gai1 did not alter the basal BRET (Fig. 8H) . These results suggest that Ga interactions at the GPR motif do not alter RGS domain function on a separate G protein.
Discussion
The primary goal of this work was to compare and determine the effects of a conventional RGS protein (RGS4) with those of an unconventional RGS protein with two G protein-binding domains (RGS14) on G protein activation/deactivation kinetics and Gbc signaling. Many conventional RGS proteins interact directly with the receptor/G protein complex by one or more mechanisms to deactivate both Ga and Gbc signaling (Neitzel and Hepler 2006) . RGS14, by contrast, with both a GPR motif and an RGS domain, exerts unique regulation of G protein signaling that has yet to be fully elucidated. Our previous work revealed that RGS14 can bind two Ga subunits simultaneously, one active Ga-GTP at the RGS domain and one inactive Ga-GDP at the GPR motif (Brown et al. 2015b) . In vitro GTPase assays showed that binding of inactive Ga-GDP to the GPR motif does not alter the GAP function of the RGS domain (Brown et al. 2015b) . While this biochemical assessment provided key insights into the mechanics of RGS14 function, how this information would translate to a cellular environment remained unclear. Moreover, these previous findings did not clarify the effects RGS14 regulation of Ga would have on Gbc signaling. Two possible models exist: (1) the RGS domain of RGS14 could operate independently of the GPR motif and serve as a dedicated GAP that deactivates both Ga and Gbc signaling, similar to other conventional RGS proteins, or (2) the RGS domain and the GPR motif could work cooperatively to deactivate and capture a single inactive Gai-GDP, thereby preventing G protein heterotrimer reassociation and prolonging Gbc signaling. Our findings in this study are most consistent with the former model, and suggest that the GPR motif is functionally silent in regulating RGS14 GAP activity in a cellular context. This model suggests that RGS14 may exist as a preformed dimeric complex with Gai-GDP at membranes, positioned to act as a GAP on a separate nearby GPCR/G protein signaling event without prolonging Gbc signaling.
Gao releases more free Gbc than Gai1
Upon examining DBRET in our reconstituted GPCR/G protein signaling system, an apparent difference in free Gbc released by Gao and Gai1 emerged. Activation of Gao-containing heterotrimers resulted in an approximately threefold greater increase in Gbc-GRK BRET activity (indicative of release of free Gbc) than that observed for activation of Gai1-containing heterotrimers. Similar studies examining Gbc release have also demonstrated larger maximum DBRET signals from Gao than Gai1 transfected with similar Ga:Gbc ratios as we present here (Masuho et al. 2015b) . Reasons for this difference in free Gbc release from the two different Ga are unclear, but could be due to differential delivery of Gao heterotrimers to the plasma membrane than Gai1. Alternatively, differential coupling efficiency of heterotrimers with the GPCR or differential dissociation of heterotrimers after activation could underlie these differences. These possibilities are not mutually exclusive and both may contribute to the phenomena observed. In a study examining the release of free Gbc dimers from Gao and Gai1, Gbc was more readily released from Gao activation suggesting Gai1 may have a higher affinity for Gbc than Gao (Digby et al. 2008) . In vitro analysis of G protein affinities revealed Gai1 has a higher affinity for Gbc than Gao (Sarvazyan et al. 2002) . Thus, the differences we observe in free Gbc release may be due to the higher affinity of Gai1 for Gbc than Gao. release of free Gbc (DBRET). Moreover, increased RGS expression resulted in increased rates of deactivation for both Gao and Gai1 proteins. The BRET signal amplitude is governed by the balance of activation (release of Gbc from Ga), and deactivation of G protein heterotrimers, measured indirectly as release of Gbc from the GRK BRET sensor. As RGS proteins stimulate G protein GTPase activity, RGS proteins accelerate the deactivation rate and lower the DBRET signal as fewer G proteins are active upon addition of agonist. This was observed in the present work since increased RGS expression resulted in decreased DBRET. The increase in deactivation rate due to RGS14 was relatively small (approximately twofold), especially when compared to the profound (more than 100-fold) increase in the rate of Ga GTPase stimulated by RGS proteins in biochemical assays using pure proteins (Ross and Wilkie 2000) . Several factors likely contribute to this discrepancy. At a technical level, our assays were limited by the amount of RGS14 that could be transfected (30 ng) because additional RGS14 greatly reduced the DBRET so that deactivation curves could not be reliably fit, thereby limiting our interpretation. Other cellular factors also must be considered. First, the GTPase acceleration by RGS defined biochemically compares a Ga in the absence of RGS to one in the presence of RGS. However, our cell-based studies compare a G protein with endogenous RGS to a G protein with endogenous plus additional exogenous RGS. Therefore, the basal Ga GTPase state in HEK cells is not RGSnull, and the basal deactivation rate of Ga in cells is faster due to the presence of endogenous RGS (Lambert et al. 2010) . Thus, the relatively small increase in deactivation rate (twofold) we observe in HEK cells with addition of recombinant RGS14 or RGS4 is very similar to the modest effects previously reported. Second, the Gbc-GRK BRET assay does not directly measure Ga GTPase activity and heterotrimer reassociation, but rather it directly measures Gbc association with and dissociation from the GRK BRET sensor. Thus, one possible contribution to the slow Gbc deactivation rate may be that the rate of release of Gbc from GRK is slower than the rate of RGS-directed formation of Ga-GDP. Consistent with this idea, the rate of deactivation of GIRK channels is increased only fourto fivefold by RGS4 (Doupnik et al. 2004) , in this case also reflecting the rate of dissociation of Gbc from GIRK, and is much slower than the accelerated rate of Ga-GTP hydrolysis stimulated by RGS4 (Ross and Wilkie 2000) . Lastly, the BRET tag on the Gbc may impede heterotrimer reassociation and/or the presence of endogenous Gbc may compete with recombinant protein.
Given these caveats, we also determined whether the increase in rate of G protein deactivation by RGS14 was due solely to the RGS domain or had contributions from the GPR motif. Expression of an RGS-null mutant of RGS14 (E92A/N93A) abolished the increase in deactivation rate observed with RGS14-WT, whereas expression of a GPR-null mutant of RGS14 (Q515A/R516A) did not alter the deactivation rate observed with RGS14-WT. These results highlight the fact that the deactivation of G protein signaling by RGS14 is due solely to the RGS domain, and that the GPR motif does not slow reassociation of heterotrimers. We postulate that the RGS14 association with Gai1-GDP via the GPR motif likely serves a primary role of stably anchoring RGS14 to membranes (Shu et al. 2007 ), but plays no role in the regulation of RGS14 GAP activity (Brown et al. 2015b ).
RGS14 does not alter the formation of Gai1 heterotrimers with Gbc
Binding of Gai1 by the RGS14 GPR motif and Gbc are mutually exclusive (Kimple et al. 2002; Mittal and Linder 2004; Shu et al. 2007) . Previous in vitro studies have suggested that the RGS14 GPR motif cannot displace Gbc from a preformed Gabc heterotrimer (Mittal and Linder 2006) . However, other studies have suggested that an isolated RGS14 GPR motif peptide can prevent heterotrimer assembly in vitro, and alter Gbc signaling to GIRK channels in response to D2S dopamine receptor activation (Webb et al. 2005) . To examine whether co-expression of RGS14 alters the basal formation of Gabc heterotrimers in cells, we examined basal BRET prior to agonist stimulation. Since the RGS14 GPR motif is selective for Gai1 (Hollinger et al. 2001 ), we expected co-expression of RGS14 to disrupt basal BRET in Gai1-expressing cells, but not Gao-expressing cells. However, in cells expressing either Gai1 or Gao, we saw no difference in basal BRET upon co-expression of RGS14. These results suggest that RGS14 does not alter the assembly of Gabc heterotrimers in live cells, consistent with previous observations with purified proteins (Mittal and Linder 2006) . Although RGS14 does not appear to disrupt the basal formation of Gabc heterotrimers, it may be able to bind Ga-GDP following a GPCR-mediated signaling event. As the GPR motif does not bind Gao (Hollinger et al. 2001 ), we did not see a difference in return to baseline BRET in cells expressing Gao (Fig. 4) . Surprisingly, we also did not see a difference in return to baseline in cells expressing Gai1 (Fig. 5) . These results suggest that RGS14 does not interfere with heterotrimer assembly prior to or after agonist stimulation, and does not prolong Gbc signaling, suggesting that RGS14 may be prebound to the plasma membrane by a distinct Gai that is bound to the GPR motif and uninvolved with the receptor signaling event.
Previous experiments demonstrating the RGS14 GPR motif could disrupt heterotrimer formation were performed with isolated GPR motif peptides (Webb et al. 2005; Mittal and Linder 2006) , while the present experiments were performed with the full-length RGS14 protein. It is possible that an isolated GPR motif behaves differently than a GPR motif in a full-length RGS14 protein. The effect of an isolated RGS14 GPR motif on Gbc release was not investigated in this study because a mammalian truncation expression construct containing only the GPR motif does not express well in HEK 293 cells (unpubl. obs.). Moreover, our investigation focused on the full-length RGS14 as we attempt to understand the interdomain regulation of G proteins by RGS14.
Interactions of the GPR motif with Gai1 does not alter RGS14 GAP activity of the RGS domain toward Gao
The presence of a second G protein-binding motif (GPR) in RGS14 presents a unique mechanism for further regulation of G protein signaling in addition to the RGS domain. Previously we have demonstrated that upon co-expression of inactive Gai1, RGS14 is targeted to the plasma membrane (Shu et al. 2007; Brown et al. 2015b) where it can associate with GPCRs via Ga (Vellano et al. 2011) . We previously proposed that GPR associations with membranebound G proteins could facilitate RGS14 RGS GAP activity by physically bringing RGS14 to the site of G protein signaling (Brown et al. 2015b) . Recent evidence suggests that membrane association of R7 RGS family members, specifically RGS7 and RGS9-2, potentiated the GAP effect of the RGS domain (Muntean and Martemyanov 2016) . Results obtained in this study suggest that RGS14 association with the plasma membrane via the GPR motif does not enhance the deactivation kinetics of RGS14-accelerated G protein deactivation (Fig. 8) . Taken together, these results suggest that the RGS domain and GPR motif function independently from one another, perhaps on distinct Ga -one involved with receptor signaling and a second that anchors RGS14 to the plasma membrane.
While we did not observe a change in Gao kinetics upon co-expression of Gai1, our studies do not address the possibility that our treatment of cells with pertussis toxin may have altered the ability of Gai1 to recruit RGS14 to the site of G protein activation. Previously, we and others have shown that GPR-containing proteins can associate with GPCRs (Vellano et al. 2011; Robichaux et al. 2015) , an association that is dependent on Ga. Pertussis toxin-mediated uncoupling of receptor/Gai1 may not optimally position RGS14:Gai1 complexes to favor interaction with GPCRs. However, given that these studies were completed with expressed recombinant proteins, the density of G proteins at the plasma membrane likely favored RGS14:Gai1 complex placement near GPCRs.
Concluding remarks
Here, we compared the effects of distinct RGS proteins on Gai/o heterotrimeric signaling. Our results indicate that the conventional RGS protein RGS4 and the unconventional RGS14 each similarly limit the release of free Gbc and accelerate the deactivation rate of Ga. The GAP effect of RGS14 is solely due to the RGS domain since binding of an inactive G protein to the GPR motif does not alter the GAP effect of the RGS domain. The results presented here suggest the RGS domain and GPR motif do not coordinate to regulate G protein signaling. We propose that despite RGS14 containing two Ga interaction sites, the GPR motif serves to anchor RGS14 in complex with Gai-GDP at membranes independently of Gbc and is functionally silent with regard to RGS domainmediated GAP activity.
